
Bioorganic and Medicinal Chemistry Letters p. 473 - 476 (1998)
Update date:2022-08-04
Topics:
Zimmerman, Dennis M.
Cantrell, Buddy E.
Smith, Edward C.R.
Nixon, James A.
Bruns, Robert F.
Gitter, Bruce
Hipskind, Philip A.
Ornstein, Paul L.
Zarrinmayeh, Hamideh
Britton, Thomas C.
Schober, Douglas A.
Gehlert, Donald R.
The characterization of a novel series of NPY-1 receptor antagonists derived from the 4-methylbenzimidazole 4 is described. Appropriate substitution on the piperidyl nitrogen of 4 led to systematic increases in Y-1 receptor affinity, to approximately 50-fold, and to the discovery of the importance of a second basic substituent.
View MoreChengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Jinhua Haoyuan Chemical CO., LTD(expird)
Contact:86-579-82465583
Address:Jinhua,Zhejiang
Nanjing Qirui Material Co., Ltd.
Contact:+86-25-52320053
Address:F4-5, #17 Building, Chuang Yi Yuan, No.6 Guanghua East Street, Nanjing, 210007 P.R.China
Chengdu Pukang Biotechnology Co., Ltd
Contact:+86-28-82550498
Address:No. 558 Rulin Road,Xinjin county,Chengdu city, China
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
Doi:10.1002/asia.201801454
(2018)Doi:10.1246/bcsj.34.1846
(1961)Doi:10.1002/jhet.5570350235
(1998)Doi:10.1134/S1070363219040169
(2019)Doi:10.1021/jo9803434
(1998)Doi:10.1016/S0040-4039(01)00101-0
(2001)